BRB Award
In Vascular Biology & Thrombosis Research
The Bernd R. Binder Publication Prize was established in Memory of the founder of Technoclone Prof. Dr. Bernd R. Binder (1945-2010) to promote young scientists who have shown an outstanding contribution to the field of Vascular Biology and Thrombosis Research.
This prize underlines Technoclone's tradition in fostering and supporting innovative research in academia an outstanding contribution to the field of Vascular Biology and Thrombosis Research.
Bernd R. Binder Publication Price 2022
Application for the Bernd R. Binder Publication Price 2022 will be possible from beginning 2023 on. Further information will be available on this website or on our social media accounts.
We look forward receiving your application!
About the BRB Publication Price
One award of € 2,500.- to the first author of an excellent original article in the areas of Vascular Biology and Thrombosis Research published in an international peer-reviewed journal.
Applicants are first author of a publication from an independent research institution (university, public research institute, etc.) in the area of Vascular Biology and/or Thrombosis Research.
The paper must be a journal article published (in print or online) in an international peer-reviewed journal in the corresponding year.
The prize will be awarded following the recommendation of a selected prize award committee.
The awardee has to agree to present the paper at the Bernd R. Binder Memorial Lecture.
For any further questions please contact awards@technoclone.com
Previous Winners of the BRB Publication Price
| Year | Name | Article |
|
2021 |
Dimitris Tsiantoulas |
“APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans“ Nature 2021;597(7874):92-96 |
| 2019/2020 |
Anja Nitzsche |
Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke |
| 2018 | Lynda Zeboudj |
Selective EGF-Receptor Inhibition in CD4þ T Cells Induces Anergy and Limits Atherosclerosis |
| 2017 |
|
Host DNases prevent vascular |
| 2016 |
Dr. Emiel van der Vorst |
High-Density Lipoproteins Exert Pro- |
| 2015 |
Dr. Katrin F. Nickel |
The polyphosphate-factor XII pathway |
| 2014 |
Dr. Andrew Sage |
MHC Class II-Restricted Antigen |
| 2013 |
Dipl. Bio Martin Schmitt |
Endothelial JAM-A guides monocytes into |
|
2012
|
*Nikolina Papac-Milicevic *lecture only |
The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circulation Research 2012; 110 (8):e50-63 |